Literature DB >> 23803011

Risk factor burden predicts long-term mortality after cerebral infarction.

G Gjerde1, H Naess.   

Abstract

OBJECTIVE: Previous studies have shown significant association between the number of traditional risk factors and long-term mortality of cerebral infarction in young stroke patients. The aim was to investigate risk factors separately and in sum in relation to long-term mortality after cerebral infarction, irrespective of age.
MATERIALS AND METHODS: Long-term mortality in relation to number of traditional risk factors (angina pectoris, myocardial infarction, intermittent claudication, hypertension, diabetes mellitus, and smoking at the time of the index stroke) and etiology was studied in patients with acute cerebral infarction admitted to the Stroke Unit, Department of Neurology, Haukeland University Hospital, between February 2006 and February 2011. Only patients alive 30 days after stroke onset were included. Cox regression analyses were performed.
RESULTS: After a mean follow-up time of 2.4 years, 14% with no risk factors had died, while the corresponding frequencies in patients with 1-3 or more risk factors were 13%, 19%, and 26%, respectively (P < 0.001). The number of risk factors was associated with mortality on Cox regression analysis (HR = 1.3, P < 0.001).
CONCLUSION: Increasing number of traditional risk factors is associated with long-term mortality in patients with cerebral infarction, irrespective of age. Careful long-term follow-up is important, especially among patients with several risk factors.
© 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  cerebral infarction; long-term mortality; traditional risk factors

Mesh:

Year:  2013        PMID: 23803011     DOI: 10.1111/ane.12159

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  9 in total

1.  Reduced Serum Level of Interleukin-10 is Associated with Cerebral Infarction: A Case-Control and Meta-Analysis Study.

Authors:  Yifei Zhu; Haiqing Yang; Zengyan Diao; Yi Li; Chuanzhu Yan
Journal:  Mol Neurobiol       Date:  2015-08-08       Impact factor: 5.590

2.  Combined effects of age and polymorphisms in Notch3 in the pathogenesis of cerebral infarction disease.

Authors:  Chun-Yu Zhu; Yue Wang; Qing-Xuan Zeng; Yu Qian; Huan Li; Zi-Xia Yang; Ya-Mei Yang; Qiong Zhang; Fei-Feng Li; Shu-Lin Liu
Journal:  Metab Brain Dis       Date:  2016-07-02       Impact factor: 3.584

3.  Weekly variations of stroke occurrence: an observational cohort study based on the Kyoto Stroke Registry, Japan.

Authors:  Kazuo Shigematsu; Yoshiyuki Watanabe; Hiromi Nakano
Journal:  BMJ Open       Date:  2015-03-24       Impact factor: 2.692

4.  Blood pressure control to prevent decline in cognition after stroke.

Authors:  Hege Ihle-Hansen; Bente Thommessen; Morten W Fagerland; Anne R Øksengård; Torgeir B Wyller; Knut Engedal; Brynjar Fure
Journal:  Vasc Health Risk Manag       Date:  2015-06-09

5.  Case-fatality and disability in the Tanzanian Stroke Incidence Project cohort.

Authors:  R W Walker; K Wakefield; W K Gray; A Jusabani; M Swai; F Mugusi
Journal:  Acta Neurol Scand       Date:  2015-05-05       Impact factor: 3.209

6.  Risk factors and their impact on carotid intima-media thickness in young and middle-aged ischemic stroke patients and controls: the Norwegian Stroke in the Young Study.

Authors:  Annette Fromm; Øystein Ariansen Haaland; Halvor Naess; Lars Thomassen; Ulrike Waje-Andreassen
Journal:  BMC Res Notes       Date:  2014-03-26

7.  Tocilizumab inhibits neuronal cell apoptosis and activates STAT3 in cerebral infarction rat model.

Authors:  Shaojun Wang; Jun Zhou; Weijie Kang; Zhaoni Dong; Hezuo Wang
Journal:  Bosn J Basic Med Sci       Date:  2016-01-15       Impact factor: 3.363

8.  Association between genetic polymorphisms of interleukins and cerebral infarction risk: a meta-analysis.

Authors:  Jiantao Wang; Niannian Fan; Yili Deng; Jie Zhu; Jing Mei; Yao Chen; Heng Yang
Journal:  Biosci Rep       Date:  2016-11-03       Impact factor: 3.840

9.  RBPJ polymorphisms associated with cerebral infarction diseases in Chinese Han population: A Clinical Trial/Experimental Study (CONSORT Compliant).

Authors:  Qiong Zhang; Jie Zhou; Hong Lei; Chun-Yu Zhu; Fei-Feng Li; Dong Zheng; Shu-Lin Liu
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.